NCT02206516View on ClinicalTrials.gov

Feasibility of Transcranial Direct Current Stimulation (tDCS) in the Treatment of Adult Attention Deficit Disorder (ADD).

PHASE1UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2018

Conditions
Adult Attention Deficit Disorder
Interventions
DEVICE

Transcranial Direct Current Stimulation

Trial Locations (1)

Unknown

TASMC, Tel Aviv

Sponsors
All Listed Sponsors
collaborator

ElMindA Ltd

INDUSTRY

collaborator

Brainsway

INDUSTRY

collaborator

Ornim Medical Ltd.

INDUSTRY

lead

Tel-Aviv Sourasky Medical Center

OTHER_GOV

NCT02206516 - Feasibility of Transcranial Direct Current Stimulation (tDCS) in the Treatment of Adult Attention Deficit Disorder (ADD). | Biotech Hunter | Biotech Hunter